| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/09/2008 | EP1874736A2 Fused heterocyclic compounds |
| 01/09/2008 | EP1874734A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 01/09/2008 | EP1874732A1 Pyrazole derivatives as progesterone receptor antagonists |
| 01/09/2008 | EP1874304A2 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 01/09/2008 | EP1874303A1 Pyrazole compounds as prostaglandin receptors ligands |
| 01/09/2008 | EP1608647B1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 01/09/2008 | EP1556378B1 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 01/09/2008 | EP1501828B1 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP0850227B1 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 01/09/2008 | CN101103026A Bicyclic heteroaryl derivatives for treating viruses |
| 01/09/2008 | CN101103022A New carboxylic acid amide used as XA inhititor |
| 01/09/2008 | CN100360615C Process for preparing azo compound |
| 01/09/2008 | CN100360528C Preparation of 4-amino-1-(2-methylol-1,3-oxapentane-5-group)-2(1H)-pyrimidone |
| 01/09/2008 | CN100360527C CB 1 receptor inverse agonists |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360512C Biphenylmethyl-thiazolidinediones and analogues and their use as PPAR-gamma activators |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317100 C4-demethyl-epothilones or C4-bisnor-epothilones from reacting 2S,6R,7S,9S)-6,7-Epoxy-9-hydroxy-2,6,10-trimethyl-11-(2-methyl-4-thiazolyl)-undec-10-en-1-al with and ethylketone carboxylic acid; macrolactonizing the acid; antitumor, anticancer, antiproliferative |
| 01/08/2008 | US7317032 Imidazolyl inhibitors of 15-lipoxygenase |
| 01/08/2008 | US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer |
| 01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
| 01/08/2008 | US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | US7317006 Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/08/2008 | CA2192433C Anti-herpesvirus compounds and methods for identyfying, making and using same |
| 01/03/2008 | WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | WO2008002571A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002570A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002569A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008001956A1 Therapeutic agent for liver fibrosis |
| 01/03/2008 | WO2008000950A2 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 01/03/2008 | WO2008000834A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 01/03/2008 | WO2008000645A1 Tetrazole-substituted arylamides |
| 01/03/2008 | WO2008000483A2 Phenol derivatives for the treatment of respiratory diseases |
| 01/03/2008 | WO2008000421A2 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 01/03/2008 | WO2007125374A3 Novel process for production of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone) |
| 01/03/2008 | WO2005019200A3 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 01/03/2008 | US20080004446 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004325 PTP1B inhibitors |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof |
| 01/03/2008 | CA2659762A1 Thiazoline and oxazoline derivatives and their methods of use |
| 01/03/2008 | CA2657107A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2657096A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | CA2655568A1 Organic compounds |
| 01/03/2008 | CA2655404A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 01/03/2008 | CA2654915A1 Tetrazole-substituted arylamides |
| 01/03/2008 | CA2654650A1 Organic compounds |
| 01/03/2008 | CA2652852A1 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 01/02/2008 | EP1871771A1 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 01/02/2008 | EP1871764A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists |
| 01/02/2008 | EP1871762A2 Subtituted heteroaryl cb1 antagonists |
| 01/02/2008 | EP1753760B1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/02/2008 | EP0819133B1 Covalently linked oligonucleotide minor groove binder conjugates |
| 01/02/2008 | CN101098869A 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 01/02/2008 | CN101098864A Anthranilamide derivatives as insecticides |
| 01/02/2008 | CN101098862A New 3-phenylpropionic acid derivatives and their use as ppar-gamma rezeptor liganden |
| 01/02/2008 | CN101098844A Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/02/2008 | CN101096369A Oxazolidinone compound containing thiadiazoles groups and preparation method thereof |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/02/2008 | CN100359014C Novel epothilones compound and its preparation method and application |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358889C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 01/02/2008 | CN100358877C Process for preparation of fungicidal compositions |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
| 01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 01/01/2008 | US7314878 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| 01/01/2008 | US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 12/27/2007 | WO2007150010A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 12/27/2007 | WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
| 12/27/2007 | WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 12/27/2007 | WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof |
| 12/27/2007 | WO2007148676A1 Therapeutic or prophylactic agent for leukemia |
| 12/27/2007 | WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 12/27/2007 | WO2007148141A1 Process for the synthesis of benzylidene rosiglitazone base |
| 12/27/2007 | WO2007147778A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 12/27/2007 | WO2007147336A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 12/27/2007 | WO2007147311A1 2-substituted benzothiazo-1,2,4-triazolinone derivatives, the preparation methods and herbicidal effects thereof |
| 12/27/2007 | WO2007120980A3 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 12/27/2007 | WO2007092751A3 Compounds and methods for modulating fx-receptors |